Hooked on oxy: How pilfered Canadian pills are fuelling a U.S. health crisis

July 14, 2014 – Anna Mehler Paperny, Global News

Nineteen thousand, two hundred and thirty-seven tablets.

That’s how many pills an Ontario pharmacy employee was able to steal before being caught in February – by far the biggest oxycodone theft reported from a Canadian hospital or pharmacy since January 2012, according to numbers Health Canada gave Global News.

Continue reading

Ontario has no plans to crack down on skyrocketing painkillers

 

July 14, 2014 – Anna Mehler Paperny, Global News

Canada’s next painkiller crackdown won’t come from Ontario.

Its removal of OxyNEO from the Ontario Drug Benefit successfully sidelined Purdue’s replacement for what was once the most notoriously addictive opioid – OxyContin.

And the province now collects data on all prescriptions filled, not just those the government pays for.

But tackling Canada’s fastest-growing addiction is turning into a game of whack-a-mole: Prescriptions for just about every other potent painkiller are up – way up – in the past two years.

Continue reading

Reality check: Is Health Canada giving addicts free heroin?

Anna Mehler Paperny – Global News

The short answer is yes. Kinda: Health Canada has approved funding for medically administered heroin for 16 addicts – and only these 16 – under its Special Access Program. The program’s designed to provide nonmarketed drugs to people suffering from “serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable.”

It has since been slammed by Health Minister Rona Ambrose on the grounds that its decision contradicts Conservative government policy.

Continue reading

Ontario considers changing who prescribes opioids, and how

ontario opioid deaths

Anna Mehler Paperny, Global News

Ontario Health Minister Deb Matthews wants to re-examine who’s allowed to prescribe opioids, how they prescribe them and what pills the government pays for.

The drop in OxyContin and its replacement OxyNEO is “a success,” she told Global News in an interview Tuesday. But “there’s more to be done. … Who should be able to prescribe these drugs? What form is the right form? These are very important questions.”

Continue reading